Zobrazeno 1 - 10
of 157
pro vyhledávání: '"I Goren"'
Autor:
L. Godny, L. Reshef, T. Sharar Fischler, S. Elial-Fatal, T. Pfeffer-Gik, B. Raykhel, K. Rabinowitz, A. Levi-Barda, TT. Perets, R. Barkan, I. Goren, JE. Ollech, H. Yanai, U. Gophna, I. Dotan
Publikováno v:
Gut Microbes, Vol 14, Iss 1 (2022)
The Mediterranean diet (MED) is associated with the modification of gut microbial composition. In this pilot study, we investigate the feasibility of a microbiota-targeted MED-based lifestyle intervention in healthy subjects. MED intervention integra
Externí odkaz:
https://doaj.org/article/2427f34121f544d7a68cf7bdbe5d4e65
Autor:
B Verstockt ., S Vieujean, M Truyens, M Julsgaard, D Pugliese, D Aslan, M Prokopic, S Lim, C Viganò, S Festa, L Ramos, M J Garciá, R Plaza, D Noviello, E Savarino, D Drobne, N Imperatore, D G Ribaldone, J Van Dongen, N Teich, M Wahed, B Barberio, I Goren
Publikováno v:
Journal of Crohn's and Colitis. 17:i805-i806
Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory disease affecting skin that bears apocrine glands and is characterised by painful, deep-seated, inflamed lesions. Treatment includes antibiotics, steroids, surgery, and ada
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Y Snir, J E Ollech, N Peleg, I Avni-Biron, H Eran-Banai, Y Broitman, T Sharar-Fischler, I Goren, L Zohar, I Dotan, H Yanai
Publikováno v:
Journal of Crohn's and Colitis. 17:i324-i324
Background Patients with inflammatory bowel diseases (IBD) with an increased risk of developing colorectal carcinoma should undergo periodic surveillance colonoscopies. There is no quality metric for dysplasia detection rate (DDR) in IBD surveillance
Autor:
O Atia, I Goren, T Sharar Fischler, Y Loewenberg Weisband, S Greenfeld, R Kariv, N Ledderman, E Matz, R Magen Rimon, I Dotan, D Turner, H Yanai
Publikováno v:
Journal of Crohn's and Colitis. 17:i596-i596
Background 5-aminosalicylates (5-ASA) are widely used in Crohn's disease (CD) despite guidelines advising otherwise. In this nationwide study, we aimed to assess the outcomes of first-line 5-ASA-maintenance therapy (5-ASA-MT) compared with no-mainten
Autor:
H Yanai, T Sharar Fischler, I Goren, J Ollech, Y Snir, Y Broitman, R Barkan, T Peffer-Gik, B Raykhel, L Kutukov, A Friedeberg, M Pauker, H Eran-Banai, I Avni-Biron, I Dotan
Publikováno v:
Journal of Crohn's and Colitis. 16:i210-i211
Background There are sparse data regarding the effectiveness of novel treatment strategies for newly diagnosed patients with Crohn’s disease (CD). Data from clinical trials demonstrate 30–40% remission rates after 1-year. We aim to assess remissi
Autor:
P M Eder, B Verstock, E Culver, G Dragoni, L I Kredel, A G G de Paredes, M Kaniewska, H Leibovitzh, G Oracz, D G Ribaldone, J Wypych, A Badaoui, J F Rahier, C Bezzio, P Bossuyt, K Falloon, C F Vozzo, T Jess, L Larsen, S S Olensen, T Starzyńska, M Chaparro, D Dror, P Ellul, I Gromny, K Maciejewska, N Peleg, A B G Shitrit, Ł Szwed, R Talar-Wojnarowska, Y Snir, E Zittan, I Goren
Publikováno v:
Journal of Crohn's and Colitis. 16:i301-i302
Background Autoimmune pancreatitis (AIP) is an uncommon inflammatory disorder that may accompany inflammatory bowel disease (IBD). The clinical relevance of AIP-IBD coexistence, therapeutic strategies, and long-term outcomes are scarcely known. Metho
Autor:
J Ollech, H Yanai, I Avni-Biron, Y Snir, H Banai, Y Broitman, I Goren, N Wasserberg, I White, I Dotan
Publikováno v:
Journal of Crohn's and Colitis. 16:i402-i403
Background Patients with ulcerative colitis (UC) after total proctocolectomy and ileal pouch-anal anastomosis (IPAA) may develop chronic pouchitis or Crohn’s like disease of the pouch (CLDP). These patients may need treatment with biologic therapie
Autor:
B Barberio, E Savarino, B Verstockt, M Fumery, D Pugliese, L Bertani, A Buda, G Dragoni, I Goren, I Laish, A Spinelli, N Teich, M Truyens, P Ellul
Publikováno v:
Journal of Crohn's and Colitis. 16:i210-i210
Background Hereditary colorectal cancer syndromes (HCCS) are rare polyposis or nonpolyposis syndromes with a higher risk of developing colorectal cancer (CRC). Coexisting inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.